Exports In 2022, Lithuania exported $272M in Nucleic Acids, making it the 16th largest exporter of Nucleic Acids in the world. At the same year, Nucleic Acids was the 34th most exported product in Lithuania. The main destination of Nucleic Acids exports from Lithuania are: United States ($112M), Germany ($74M), Switzerland ($28M), Ireland ($21.3M), and Netherlands ($15.1M).
The fastest growing export markets for Nucleic Acids of Lithuania between 2021 and 2022 were Ireland ($19.3M), Netherlands ($11.6M), and Russia ($2.29M).
Imports In 2022, Lithuania imported $75.8M in Nucleic Acids, becoming the 37th largest importer of Nucleic Acids in the world. At the same year, Nucleic Acids was the 125th most imported product in Lithuania. Lithuania imports Nucleic Acids primarily from: United States ($60.8M), China ($7.8M), Germany ($2.97M), Ireland ($1.25M), and India ($1.24M).
The fastest growing import markets in Nucleic Acids for Lithuania between 2021 and 2022 were United States ($37.2M), Ireland ($1.25M), and China ($1.24M).